
The European Commission has approved, under EU State aid rules, €511 million (US$609.67 million) in Italian support to compensate providers of commercial, long-distance rail passenger services for the damage suffered between March 8 and June 30, 2020, due to the coronavirus outbreak and the restrictive measures that Italy had to implement to limit the spread of the coronavirus.
Executive Vice-President Margrethe Vestager, in charge of competition policy, said, “Competition in the high-speed segment in Italy has been key to develop services with more capacity, frequency and connections, leading to lower prices and better quality for consumers. This €511 million aid measure will enable Italy to support long-distance rail passenger operators on commercial lines in these difficult times, by compensating them for the damage suffered as a result of the emergency measures that Italy put in place during the first wave of the pandemic. We continue to work with all Member States to ensure that national support measures can be put in place as quickly and effectively as possible, in line with EU rules.”
In the period between March 8 and June 30, 2020, the Italian government put in place an array of measures that were necessary to limit the spread of the coronavirus, including, until June 3, 2020, a general prohibition to travel across regions. Further restrictions remained in place also in June, in particular a mandatory staggered seating reservation system that cut available seats by 50%. Those mandatory restrictions severely affected long-distance rail passenger transport providers.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas